These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4093204)

  • 41. [Clinical trial of the possibility of increasing the bioavailability of mebendazole using sunflower oil in echinococcosis].
    Shcherbakov AM; Lur'e AA
    Med Parazitol (Mosk); 1989; (3):46-9. PubMed ID: 2674643
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Conservative therapy of echinococcal disease: optimization of the mebendazole dosage regimen using a computer].
    Lur'e AA; Shcherbakov AM
    Med Parazitol (Mosk); 1987; (5):13-6. PubMed ID: 3437831
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effect of phospholipids on mebendazole pharmacokinetics in experimental multilocular echinococcosis].
    Lur'e AA; Dzhabarova VI; Krotov AI; Shcherbakov AM
    Med Parazitol (Mosk); 1986; (5):67-71. PubMed ID: 3796459
    [No Abstract]   [Full Text] [Related]  

  • 44. [Optimization of the chemotherapy of echinococcal disease (the current state of the problem and the means for its resolution)].
    Shcherbakov AM
    Med Parazitol (Mosk); 1986; (5):57-61. PubMed ID: 3540558
    [No Abstract]   [Full Text] [Related]  

  • 45. [Use of plant oils to increase the bioavailability of mebendazole (in a model of larval unilocular echinococcosis)].
    Lur'e AA; Dzhabarova VI; Krotov AI; Shcherbakov AM
    Med Parazitol (Mosk); 1987; (2):19-22. PubMed ID: 3600502
    [No Abstract]   [Full Text] [Related]  

  • 46. FDA approved drugs with antiviral activity against SARS-CoV-2: From structure-based repurposing to host-specific mechanisms.
    Ahmed MS; Farag AB; Boys IN; Wang P; Menendez-Montes I; Nguyen NUN; Eitson JL; Ohlson MB; Fan W; McDougal MB; Mar K; Thet S; Ortiz F; Kim SY; Solmonson A; Williams NS; Lemoff A; DeBerardinis RJ; Schoggins JW; Sadek HA
    Biomed Pharmacother; 2023 Jun; 162():114614. PubMed ID: 37068330
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Revisiting the Effect of Pharmaceuticals on Transmission Stage Formation in the Malaria Parasite
    Thommen BT; Passecker A; Buser T; Hitz E; Voss TS; Brancucci NMB
    Front Cell Infect Microbiol; 2022; 12():802341. PubMed ID: 35223540
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reverse swing-M, phase 1 study of repurposing mebendazole in recurrent high-grade glioma.
    Patil VM; Bhelekar A; Menon N; Bhattacharjee A; Simha V; Abhinav R; Abhyankar A; Sridhar E; Mahajan A; Puranik AD; Purandare N; Janu A; Ahuja A; Krishnatry R; Gupta T; Jalali R
    Cancer Med; 2020 Jul; 9(13):4676-4685. PubMed ID: 32400117
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature.
    Guerini AE; Triggiani L; Maddalo M; Bonù ML; Frassine F; Baiguini A; Alghisi A; Tomasini D; Borghetti P; Pasinetti N; Bresciani R; Magrini SM; Buglione M
    Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31480477
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Repurposing the antihelmintic mebendazole as a hedgehog inhibitor.
    Larsen AR; Bai RY; Chung JH; Borodovsky A; Rudin CM; Riggins GJ; Bunz F
    Mol Cancer Ther; 2015 Jan; 14(1):3-13. PubMed ID: 25376612
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Food-drug interactions.
    Schmidt LE; Dalhoff K
    Drugs; 2002; 62(10):1481-502. PubMed ID: 12093316
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Chemotherapy of alveolar echinococcosis with benzimidazoles. A prospective long-term study].
    Reuter S; Kratzer W; Kurz S; Wellinghausen N; Kern P
    Med Klin (Munich); 1998 Aug; 93(8):463-7. PubMed ID: 9747101
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cimetidine increases serum mebendazole concentrations. Implications for treatment of hepatic hydatid cysts.
    Bekhti A; Pirotte J
    Br J Clin Pharmacol; 1987 Sep; 24(3):390-2. PubMed ID: 3663452
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical pharmacokinetics of anthelmintic drugs.
    Edwards G; Breckenridge AM
    Clin Pharmacokinet; 1988 Aug; 15(2):67-93. PubMed ID: 3064952
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum concentrations of mebendazole in patients with hydatid disease.
    Bekhti A
    Int J Clin Pharmacol Ther Toxicol; 1985 Dec; 23(12):633-41. PubMed ID: 4093204
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma concentrations of mebendazole during treatment of echinococcosis: preliminary results.
    Münst GJ; Karlaganis G; Bircher J
    Eur J Clin Pharmacol; 1980 May; 17(5):375-8. PubMed ID: 7418715
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Combined chemotherapy (mebendazole plus praziquantel) in patients with hydatidosis].
    Salto E; Juárez E; Roiz MP; Abad J
    Enferm Infecc Microbiol Clin; 1991 Nov; 9(9):527-9. PubMed ID: 1822703
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A correlation between serum mebendazole concentrations and the aminopyrine breath test. Implications in the treatment of hydatid disease.
    Bekhti A; Pirotte J; Woestenborghs R
    Br J Clin Pharmacol; 1986 Feb; 21(2):223-6. PubMed ID: 3082346
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of hydatid disease with high oral doses of mebendazole. Long-term follow-up of plasma mebendazole levels and drug interactions.
    Luder PJ; Siffert B; Witassek F; Meister F; Bircher J
    Eur J Clin Pharmacol; 1986; 31(4):443-8. PubMed ID: 3816925
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.